HIV News and Research

RSS

Valproic acid may help slow the progression of dementia

Researchers have found that a common anticonvulsant drug improved cognitive function and appeared to restore nerve cells in the brains of patients with HIV-related dementia. The results of the Phase I clinical trial are published in the March issue of the scientific journal Neurology.

14 Mar 2006

Antiretroviral therapy (ART) drugs unlikely to stop HIV spread

Researchers believe antiretroviral therapy (ART) will not be effective in stopping HIV epidemics even if it is made universally available in poorer countries, and that widespread use could even lead to an increase in the numbers infected with HIV.

14 Mar 2006

Researchers find a way to make plants produce more antigens needed for vaccines

Scientists have developed a new kind of molecule which they believe could ultimately lead to the development of a vaccine against HIV using genetically modified tobacco.

13 Mar 2006

Photodynamic therapy may be an effective treatment for infections of the oral cavity

Researchers found that the bacteria S. mutans, as well as fungal organisms of the genus Candida, cultured from HIV patients, were highly susceptible to killing with minimal doses of PDT, both in laboratory dishes and on biofilms grown on denture material.

13 Mar 2006

Completely novel approach to fighting HIV infections

For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second.

13 Mar 2006

New test for detecting small amounts of proteins in the blood

Researchers at the University of Pennsylvania School of Medicine have developed a paradigm-shifting method for detecting small amounts of proteins in the blood.

13 Mar 2006

Breakthrough in fast, disposable DNA testing

Thermal Gradient announced today that it has successfully developed a 30-cycle PCR device that can amplify DNA in just 4.4 minutes, far faster than anything available in the marketplace.

9 Mar 2006

Antiretroviral therapy (ART) should be strongly considered in the management of infants infected with HIV

Antiretroviral therapy (ART) for infants born with HIV infection may be most effective when given in their first five months of life, according to a study published in the April 1 issue of The Journal of Infectious Diseases.

9 Mar 2006

Tibotec Pharmaceuticals receives NDA for investigational HIV protease inhibitor

Tibotec Pharmaceuticals has announced that the New Drug Application (NDA) for TMC114, an investigational HIV protease inhibitor, has been accepted for priority review by the United States Food and Drug Administration (FDA).

7 Mar 2006

Researchers gain key insights into how different types of infection-fighting T-cells survive

T-cells, or lymphocytes, are the body's natural defense mechanism against infection, directly attacking foreign bodies such as bacteria and viruses.

7 Mar 2006

Veterans research indicates mantrams can control post-traumatic stress disorder

Repeating mantrams can help control the symptoms of post-traumatic stress disorder, have a calming effect in traffic and even ease the boredom of exercise, according to a study in the latest issue of Journal of Advanced Nursing.

6 Mar 2006

Schering-Plough provides update on phase II study of Vicriviroc

Schering-Plough Corporation has provided an update on vicriviroc, its investigational CCR5 receptor antagonist, currently being evaluated by the NIH-sponsored Adult AIDS Clinical Trials Group (ACTG) in an ongoing Phase II clinical study of 118 U.S. treatment-experienced HIV patients.

6 Mar 2006

Malnutrition the root cause of half of all child deaths

According to a report by the World Bank, malnutrition is now costing poor countries as much as 3% of their annual economic output and is stunting economic development.

5 Mar 2006

Fighting the battle against disease - Leeds researchers take on the world

The five-year project will help ensure that the best treatments reach those in most need as quickly as possible, and that effective healthcare systems are established to prevent the spread of disease.

1 Mar 2006

The incidence, distribution, and control of tuberculosis

A reduction in tuberculosis (TB) incidence, prevalence and death rate can be achieved by 2015 in most parts of the world, with the greatest challenges occurring in Africa and Eastern Europe, according to a projection by the Stop TB Department of the World Health Organization.

1 Mar 2006

HAART is very cost-effective

New research shows that highly active antiretroviral therapy (HAART) is very cost-effective, despite the high price tag. However, the study also shows that reimbursement to physicians treating patients with HIV is critically low, threatening patients' access to care.

1 Mar 2006

Combination therapy improves Acquired Immunodeficiency Syndrome-Related Lymphoma outcome

Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma, according to a new study.

27 Feb 2006

HIV/AIDS risks reduced when mothers educate daughters

Low-income African American teen girls in Chicago continue to be at high risk for contracting HIV, but the risk decreases when their mothers teach them about the dangers of the disease, according to a new study at the University of Illinois at Chicago.

24 Feb 2006

British man had to cheat to access to HIV treatment

'Robert' says a therapy known as PEP, post-exposure prophylaxis, is not widely available and has not been well publicised and he is seeking a judicial review of government policy.

23 Feb 2006

Getting help with sexual health getting worse instead of better in the UK

According to a newly released survey, regardless of increased government spending, sexual health clinics in Britain are worse now than they were three years ago.

23 Feb 2006